Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Pinzan, Camila Figueiredo ^a   Sardinha Silva, Aline ^a   Almeida, Fausto ^a   Lai, Livia ^b   Lopes, Carla Duque ^a   Lourenço, Elaine Vicente ^c   Panunto Castelo, Ademilson ^a   Matthews, Stephen ^b   Roque Barreira, Maria Cristina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; PROTEIN MIC1; PROTEIN MIC4; PROTEIN MIC6; RECOMBINANT PROTEIN; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG; VACCINE; CYTOKINE; PROTOZOAL PROTEIN; PROTOZOAL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; INFECTION PREVENTION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PARASITE LOAD; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TOXOPLASMOSIS; ANIMAL; BIOSYNTHESIS; BLOOD; BRAIN; C57BL MOUSE; CELL CULTURE; ESCHERICHIA COLI; IMMUNOLOGY; PARASITOLOGY; TOXOPLASMA; VACCINATION;

ANIMALS; BRAIN; CELLS, CULTURED; CYTOKINES; ESCHERICHIA COLI; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MICE, INBRED C57BL; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS; VACCINATION;

EID: 84956686769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143087     Document Type: Article

References (61)

1. Cook GC. Toxoplasma gondii infection: a potential danger to the unborn fetus and AIDS sufferer. The Quarterly journal of medicine. 1990; 74(273):3-19. PMID: 2183258
2. Dodds EM. Toxoplasmosis. Current opinion in ophthalmology. 2006; 17(6):557-61. PMID: 17065925
3. Luft BJ, Remington JS. AIDS commentary. Toxoplasmic encephalitis. The Journal of infectious diseases. 1988; 157(1):1-6. PMID: 3121758
4. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1992; 15(2):211-22.
5. de Medeiros BC, de Medeiros CR, Werner B, Loddo G, Pasquini R, Bleggi-Torres LF. Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transplant infectious disease: an official journal of the Transplantation Society. 2001; 3(1):24-8.
6. Escuissato DL, de Aguiar RO, Gasparetto EL, Muller NL. Disseminated toxoplasmosis after bone marrow transplantation: high-resolution CT appearance. Journal of thoracic imaging. 2004; 19(3):207-9. PMID: 15273620
7. Israelski DM, Remington JS. Toxoplasmosis in patients with cancer. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1993; 17 Suppl 2:S423-35.
8. Dubey JP, Hill DE, Jones JL, Hightower AW, Kirkland E, Roberts JM, et al. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. The Journal of parasitology. 2005; 91(5):1082-93. PMID: 16419752
9. Zou FC, Sun XT, Xie YJ, Li B, Zhao GH, Duan G, et al. Seroprevalence of Toxoplasma gondii in pigs in southwestern China. Parasitology international. 2009; 58(3):306-7. doi: 10.1016/j.parint.2009.06.002 PMID: 19523533
10. Maser P, Wittlin S, Rottmann M, Wenzler T, Kaiser M, Brun R. Antiparasitic agents: new drugs on the horizon. Current opinion in pharmacology. 2012; 12(5):562-6. doi: 10.1016/j.coph.2012.05.001 PMID: 22652215
11. Soeiro MN, Werbovetz K, Boykin DW, Wilson WD, Wang MZ, Hemphill A. Novel amidines and analogues as promising agents against intracellular parasites: a systematic review. Parasitology. 2013; 140(8):929-51. doi: 10.1017/S0031182013000292 PMID: 23561006
12. Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Veterinary research. 1998; 29(3-4):289-310. PMID: 9689743
13. Buxton D. Toxoplasmosis: the first commercial vaccine. Parasitology today. 1993; 9(9):335-7. PMID: 15463799
14. Verma R, Khanna P. Development of Toxoplasma gondii vaccine: A global challenge. Human vaccines & immunotherapeutics. 2013; 9(2):291-3.
15. Innes EA, Vermeulen AN. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology. 2006; 133 Suppl:S145-68. PMID: 17274844
16. Soldati D, Dubremetz JF, Lebrun M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. International journal for parasitology. 2001; 31(12):1293-302. PMID: 11566297
17. Tomley FM, Soldati DS. Mix and match modules: structure and function of microneme proteins in apicomplexan parasites. Trends in parasitology. 2001; 17(2):81-8. PMID: 11228014
18. Marchant J, Cowper B, Liu Y, Lai L, Pinzan C, Marq JB, et al. Galactose recognition by the apicomplexan parasite Toxoplasma gondii. The Journal of biological chemistry. 2012; 287(20):16720-33. doi: 10.1074/jbc.M111.325928 PMID: 22399295
19. Soldati-Favre D. Molecular dissection of host cell invasion by the apicomplexans: the glideosome. Parasite. 2008; 15(3):197-205. PMID: 18814681
20. Lourenco EV, Pereira SR, Faca VM, Coelho-Castelo AA, Mineo JR, Roque-Barreira MC, et al. Toxoplasma gondii micronemal protein MIC1 is a lactose-binding lectin. Glycobiology. 2001; 11(7):541-7. PMID: 11447133
21. Lourenco EV, Bernardes ES, Silva NM, Mineo JR, Panunto-Castelo A, Roque-Barreira MC. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii. Microbes and infection/Institut Pasteur. 2006; 8(5):1244-51. PMID: 16616574
22. Wang BL, Xu Y, Wu CQ, Xu YM, Wang HH. Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis. Protein expression and purification. 2005; 39(2):184-8. PMID: 15642469
23. Freyre A. Separation of toxoplasma cysts from brain tissue and liberation of viable bradyzoites. The Journal of parasitology. 1995; 81(6):1008-10. PMID: 8544039
24. Aliberti J. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nature reviews Immunology. 2005; 5(2):162-70. PMID: 15662369
25. Carruthers VB, Sibley LD. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. European journal of cell biology. 1997; 73(2):114-23. PMID: 9208224
26. Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC. Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS pathogens. 2005; 1 (2):e17. PMID: 16244709
27. Carruthers V, Boothroyd JC. Pulling together: an integrated model of Toxoplasma cell invasion. Current opinion in microbiology. 2007; 10(1):83-9. PMID: 16837236
28. Huynh MH, Harper JM, Carruthers VB. Preparing for an invasion: charting the pathway of adhesion proteins to Toxoplasma micronemes. Parasitology research. 2006; 98(5):389-95. PMID: 16385407
29. Besteiro S, Dubremetz JF, Lebrun M. The moving junction of apicomplexan parasites: a key structure for invasion. Cellular microbiology. 2011; 13(6):797-805. doi: 10.1111/j.1462-5822.2011.01597.x PMID: 21535344
30. Santos JM, Soldati-Favre D. Invasion factors are coupled to key signalling events leading to the establishment of infection in apicomplexan parasites. Cellular microbiology. 2011; 13(6):787-96. doi: 10. 1111/j.1462-5822.2011.01585.x PMID: 21338465
31. Carruthers VB, Tomley FM. Microneme proteins in apicomplexans. Sub-cellular biochemistry. 2008; 47:33-45. PMID: 18512339
32. Friedrich N, Santos JM, Liu Y, Palma AS, Leon E, Saouros S, et al. Members of a novel protein family containing microneme adhesive repeat domains act as sialic acid-binding lectins during host cell invasion by apicomplexan parasites. The Journal of biological chemistry. 2010; 285(3):2064-76. doi: 10. 1074/jbc.M109.060988 PMID: 19901027
33. Garcia-Reguet N, Lebrun M, Fourmaux MN, Mercereau-Puijalon O, Mann T, Beckers CJ, et al. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite. Cellular microbiology. 2000; 2(4):353-64. PMID: 11207591
34. Kessler H, Herm-Gotz A, Hegge S, Rauch M, Soldati-Favre D, Frischknecht F, et al. Microneme protein 8 - A new essential invasion factor in Toxoplasma gondii. Journal of cell science. 2008; 121(Pt 7):947-56. doi: 10.1242/jcs.022350 PMID: 18319299
35. Reiss M, Viebig N, Brecht S, Fourmaux MN, Soete M, Di Cristina M, et al. Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii. The Journal of cell biology. 2001; 152(3):563-78. PMID: 11157983
36. Blumenschein TMA, Friedrich N, Childs RA, Saouros S, Carpenter EP, Campanero-Rhodes MA, et al. Atomic resolution insight into host cell recognition by Toxoplasma gondii. Embo J. 2007; 26(11):2808-20. PMID: 17491595
37. Garnett JA, Liu Y, Leon E, Allman SA, Friedrich N, Saouros S, et al. Detailed insights from microarray and crystallographic studies into carbohydrate recognition by microneme protein 1 (MIC1) of Toxoplasma gondii. Protein Sci. 2009; 18(9):1935-47. doi: 10.1002/pro.204 PMID: 19593815
38. Saouros S, Edwards-Jones B, Reiss M, Sawmynaden K, Cota E, Simpson P, et al. A novel galectin-like domain from Toxoplasma gondii micronemal protein 1 assists the folding, assembly, and transport of a cell adhesion complex. The Journal of biological chemistry. 2005; 280(46):38583-91. PMID: 16166092
39. Cerede O, Dubremetz JF, Soete M, Deslee D, Vial H, Bout D, et al. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. The Journal of experimental medicine. 2005; 201(3):453-63. PMID: 15684324
40. Tao Q, Fang R, Zhang W, Wang Y, Cheng J, Li Y, et al. Protective immunity induced by a DNA vaccineencoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice. Parasitology research. 2013; 112(8):2871-7. doi: 10.1007/s00436-013-3458-4 PMID: 23749087
41. Yuan ZG, Ren D, Zhou DH, Zhang XX, Petersen E, Li XZ, et al. Evaluation of protective effect of pVAXTgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model. Vaccine. 2013; 31(31):3135-9. doi: 10.1016/j.vaccine.2013.05.040 PMID: 23707448
42. Liu MM, Yuan ZG, Peng GH, Zhou DH, He XH, Yan C, et al. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitology research. 2010; 106 (5):1079-84. doi: 10.1007/s00436-010-1742-0 PMID: 20177910
43. Fang R, Nie H, Wang Z, Tu P, Zhou D, Wang L, et al. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Veterinary parasitology. 2009; 164(2-4):134-40. doi: 10.1016/j.vetpar.2009.06.012 PMID: 19592172
44. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical microbiology reviews. 1998; 11(4):569-88. PMID: 9767056
45. Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol. 2012; 34(6):793-813. doi: 10.1007/s00281-012-0339-3 PMID: 22955326
46. Johnson LL, Sayles PC. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infection and immunity. 2002; 70(1):185-91. PMID: 11748181
47. Kang H, Remington JS, Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. Journal of immunology. 2000; 164(5):2629-34.
48. Konishi E, Nakao M. Naturally occurring immunoglobulin M antibodies: enhancement of phagocytic and microbicidal activities of human neutrophils against Toxoplasma gondii. Parasitology. 1992; 104 (Pt 3):427-32. PMID: 1641242
49. Fuhrman SA, Joiner KA. Toxoplasma gondii: mechanism of resistance to complement-mediated killing. Journal of immunology. 1989; 142(3):940-7.
50. Schreiber RD, Feldman HA. Identification of the activator system for antibody to Toxoplasma as the classical complement pathway. The Journal of infectious diseases. 1980; 141(3):366-9. PMID: 7365285
51. Vercammen M, Scorza T, El Bouhdidi A, Van Beeck K, Carlier Y, Dubremetz JF, et al. Opsonization of Toxoplasma gondii tachyzoites with nonspecific immunoglobulins promotes their phagocytosis by macrophages and inhibits their proliferation in nonphagocytic cells in tissue culture. Parasite Immunol. 1999; 21(11):555-63. PMID: 10583856
52. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kuhn R, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Journal of immunology. 1996; 157(2):798-805.
53. Sher A, Denkers EY, Gazzinelli RT. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. Ciba Foundation symposium. 1995; 195:95-104; discussion-9. PMID: 8724832
54. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988; 240(4851):516-8. PMID: 3128869
55. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, et al. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. Journal of immunology. 1996; 157(9):4045-54.
56. Khan IA, Matsuura T, Kasper LH. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol. 1995; 17(4):185-95. PMID: 7624159
57. Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infection and immunity. 1997; 65(5):1675-82. PMID: 9125546
58. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunology today. 1991; 12(3):A49-53. PMID: 1648926
59. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. Journal of immunology. 1991; 147(11):3815-22.
60. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, et al. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. Journal of immunology. 2000; 164 (10):5375-82.
61. McLeod R, Eisenhauer P, Mack D, Brown C, Filice G, Spitalny G. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. Journal of immunology. 1989; 142 (9):3247-55.